Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12P - Fermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture › C12P 21 - Preparation of peptides or proteins
Patents for C12P 21 - Preparation of peptides or proteins (112,499)
03/2003
03/06/2003CA2458512A1 .alpha.-1,2-fucosyl transferase and dna encoding the same
03/06/2003CA2458445A1 Extracellular messengers
03/06/2003CA2458381A1 Transmembrane protein differentially expressed in cancer
03/06/2003CA2458227A1 Method and device for integrated protein expression, purification and detection
03/06/2003CA2457879A1 Modulators of bone homeostasis identified in a high-throughput screen
03/06/2003CA2457779A1 Moraxella (branhamella) catarrhalis polypeptides and corresponding dna fragments
03/06/2003CA2456323A1 Lipopeptide stereoisomers, methods for preparing same, and useful intermediates
03/05/2003EP1288307A1 Use of fructose-1,6-bisphosphate aldolase for identifying new fungicidal substances
03/05/2003EP1288299A2 TRNA synthetase
03/05/2003EP1288229A2 Transgenic non human animals capable of producing heterologous antibodies
03/05/2003EP1288222A1 Peptidic compounds selectively binding to P-selectin
03/05/2003EP1287832A2 Use of leukemia inhibitory factor antagonist
03/05/2003EP1287830A1 Use of methioninase as an antitumor agent in anti-methionine chemotherapy
03/05/2003EP1287159A1 Enzymatic treatment of whey proteins for the production of antihypertensive peptides, the resulting products and treatment of hypertension in mammals
03/05/2003EP1287144A2 Bacterial insecticidal proteins
03/05/2003EP1287142A1 Nucleic acid molecule comprising a nucleic acid sequence coding for an sdf-1 gamma chemokine, a neuropeptide precursor or at least one neuropeptide
03/05/2003EP1287141A2 Extracellular messengers
03/05/2003EP1287140A1 Antibody molecules having specificity for human tumor necrosis factor alpha, and use thereof
03/05/2003EP1287138A1 Novel g-protein coupled receptor
03/05/2003EP1287134A2 The human voltage-gated sodium channel beta-1a subunit and methods of use
03/05/2003EP1287132A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
03/05/2003EP1287131A2 Regulator of g protein signalling (rgs8)
03/05/2003EP1287130A2 Mammalian cytokine receptor subunit proteins, related reagents and methods
03/05/2003EP1287121A2 Extracellular domain of ryk protein for regulating angiogenesis
03/05/2003EP1287115A2 Retinal pigment epithelial cell lines with extended life-span and their applications
03/05/2003EP1287035A1 An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof
03/05/2003EP1287032A2 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof
03/05/2003EP1287025A1 Sheep lice, bovicola ovis, allergen treatment
03/05/2003EP1287020A2 Cancer diagnosis and assays for screening anti-cancer agents
03/05/2003EP1287015A1 Extracellular matrix polynucleotides, polypeptides, and antibodies
03/05/2003EP1286693A1 Complexes of alpha (2) macroglobulin and antigenic molecules for immunotherapy
03/05/2003EP1286682A1 Methods and compositions for inhibiting immunoglobulin-mediated--reperfusion injury
03/05/2003EP0877795A4 Isolation of precursor cells from hematopoietic and non-hematopoietic tissues and their use
03/05/2003EP0830143B1 Use of leukemia inhibitory factor and endothelin antagonists
03/05/2003EP0791009A4 Modified neuropeptide y receptors
03/05/2003EP0728143B1 Oncoprotein protein kinase
03/05/2003EP0674704B1 NOVEL $i(BACILLUS THURINGIENSIS) STRAINS ACTIVE AGAINST LEPIDOPTERAN AND COLEOPTERAN PESTS
03/05/2003EP0656952B1 Cationic peptides and method for production
03/05/2003EP0602126B1 Immunoglobulin variants for specific fc epsilon receptors
03/05/2003CN1401003A Gene Sp17 inhibiting lesion formation in plant and utilization thereof
03/05/2003CN1401001A 5HT3 receptors of nematodes, polynucleotide molecules encoding same, and antagonists thereof
03/05/2003CN1400910A Factor VII or VIIa like molecules
03/05/2003CN1400313A Method for producing recombinant human epidermal growth factor by using gene engineering colibacillus
03/05/2003CN1400309A Large wasp sedative peptide precursor gene and its coded polypeptide and preparation method
03/04/2003WO2002020614A2 Endoglin-specific polypeptide, production and use thereof
03/04/2003US6528634 Aiolos gene
03/04/2003US6528626 Viral library for use in the diagnosis and treatment of viral diseases
03/04/2003US6528624 Comprising a human IgG Fc region with amino acid substitution at two or more positions; displays altered effector function; C1q binding affinity; complement dependent cytotoxicity
03/04/2003US6528623 Antibodies that specifically bind ACT-4-L-h-1 ligand
03/04/2003US6528487 Including GMP-140, ELAM-1, and lymphocyte-homing receptor.
03/04/2003US6528482 Receptor activator of NF-κB
03/04/2003US6528304 Eukaryotic cells expressing at their surface at least an HLA-G isoform and their applications
03/04/2003US6528297 Human lysozyme gene, its encoded polypeptide and the method for preparing them
03/04/2003US6528287 Recombinant human serum transferrins containing peptides for inducing apoptosis in HIV-1 infected cells
03/04/2003US6528284 S-Region Transfer Activity-70 (SRTA-70); can be used as therapeutic agents in immune response modulation
03/04/2003US6528283 Members of the D52 Gene family
03/04/2003US6528281 DNA encoding human interleukin-11 receptor
03/04/2003US6528276 Fusion proteins, DNA molecules, vectors, and host cells useful for measuring protease activity
03/04/2003US6528269 Monoclonal antibodies; can be used to diagnose neurodegenerative disorders
03/04/2003US6528263 Identifying a cell expressing protooncogene polypeptide by contacting a nucleic acid with a polynucleotide reagent and detecting its binding; can be used in diagnosis and treatment of cancer
03/04/2003US6528064 Recombinant trytophan mutants of influenza
03/04/2003US6528055 Polypeptide for use in the diagnosis, treatment and prevention of infections, immune response defects and autoimmune diseases
03/04/2003US6528038 An immune response directed against Porphyromonas gingivalis. The composition includes a suitable adjuvant and/or acceptable carrier and one substantially purified P. gingivalis immunogen. The immunogen is selected from the group consisting
03/04/2003CA2421202A1 Endoglin-specific polypeptide, production and use thereof
03/04/2003CA1341423C Recombinant proteins of viruses associated with lymphadenopathy syndrome and/or acquired immune deficiency syndrome
02/2003
02/27/2003WO2003016915A1 Tumor specific oligosaccharide sequences and use thereof
02/27/2003WO2003016906A1 Method of diagnosing or monitoring saccharometabolic error
02/27/2003WO2003016549A2 Nucleic-acid associated proteins
02/27/2003WO2003016538A1 A method or extracellular production of target proteins employing ompf in e. coli
02/27/2003WO2003016532A1 Human protooncogene kg-20 and protein encoded therein
02/27/2003WO2003016526A1 Method for gene expression
02/27/2003WO2003016522A2 Methods and compounds for the targeting of protein to exosomes
02/27/2003WO2003016510A1 New biopesticide using gene from erwinia pyrifoliaewt#3, novel pathogen that affects asian pear trees
02/27/2003WO2003016506A2 Secreted proteins
02/27/2003WO2003016493A2 Transporters and ion channels
02/27/2003WO2003016472A2 Hybrid interferon/interferon tau proteins, compositions and methods of use
02/27/2003WO2003016471A2 Periostin-based diagnostic assays
02/27/2003WO2003016468A2 Antagonistic anti-htnfsf13b human antibodies
02/27/2003WO2003016466A2 ANTI-Aβ ANTIBODIES
02/27/2003WO2003016464A2 Cancer specific oligosaccharide sequences and use thereof
02/27/2003WO2003016353A1 Anti-ciguatoxin monoclonal antibody
02/27/2003WO2003016349A1 A method of producing glucagon-like peptide 1(glp-1)7-36 and an glp-1 analogue
02/27/2003WO2003016339A1 A frog skin antibacterial peptide derivative
02/27/2003WO2003015915A1 Solid compositions for selective adsorption from complex mixtures
02/27/2003WO2003015819A1 Complement pathway inhibitors binding to c5 and c5a without preventing formation of c5b
02/27/2003WO2003015717A2 Tyrosine kinase inhibitors
02/27/2003WO2003015712A2 Methods for preparing compositions comprising heat shock proteins or alpha-2-macroglobulin
02/27/2003WO2003015710A2 Combined drug and csf removal therapies and systems
02/27/2003WO2003015705A2 In situ immunization
02/27/2003WO2003015697A2 Interleukin-2 mutants with reduced toxicity
02/27/2003WO2003015694A2 Agents for enhancing the immune response
02/27/2003WO2003015613A2 Molecular characteristics of non-small cell lung cancer
02/27/2003WO2002100348A3 Human monoclonal antibodies to epidermal growth factor receptor (egfr)
02/27/2003WO2002099100A3 Method of production of a protein in cells which inducibly express the cell cycle inhibitor protein, p21
02/27/2003WO2002097046A3 B7 related protein-2 molecules and uses thereof
02/27/2003WO2002080844A3 Novel bgp compounds for therapy and diagnosis and methods for using same
02/27/2003WO2002046193A3 Heterocyclic ether substituted imidazoquinolines
02/27/2003WO2002044336A3 Method of making a protein polymer and uses of the polymer
02/27/2003WO2002031156A3 Bvh-a2 and bvh-a3 antigens of group b streptococcus
02/27/2003WO2002020767A3 G-csf analog compositions and methods
1 ... 610 611 612 613 614 615 616 617 618 619 620 621 622 623 624 625 626 627 628 629 630 ... 1125